KR20160011174A - Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient - Google Patents
Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient Download PDFInfo
- Publication number
- KR20160011174A KR20160011174A KR1020150132380A KR20150132380A KR20160011174A KR 20160011174 A KR20160011174 A KR 20160011174A KR 1020150132380 A KR1020150132380 A KR 1020150132380A KR 20150132380 A KR20150132380 A KR 20150132380A KR 20160011174 A KR20160011174 A KR 20160011174A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- food composition
- functional food
- health functional
- testosterone
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 239000004480 active ingredient Substances 0.000 title claims abstract description 10
- 241000331432 Cynanchum wilfordii Species 0.000 title claims abstract description 9
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title abstract description 84
- 229960003604 testosterone Drugs 0.000 title abstract description 43
- 235000013305 food Nutrition 0.000 title abstract description 4
- 230000029142 excretion Effects 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 64
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 235000013376 functional food Nutrition 0.000 claims description 26
- 230000036541 health Effects 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000006872 improvement Effects 0.000 claims description 9
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 208000010228 Erectile Dysfunction Diseases 0.000 claims description 5
- 201000001881 impotence Diseases 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- 208000017657 Menopausal disease Diseases 0.000 claims description 4
- 230000037396 body weight Effects 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 210000001596 intra-abdominal fat Anatomy 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000012046 mixed solvent Substances 0.000 claims description 3
- 230000035946 sexual desire Effects 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 231100000469 sperm hypomotility Toxicity 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 206010027304 Menopausal symptoms Diseases 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims 1
- 230000003292 diminished effect Effects 0.000 claims 1
- 208000003532 hypothyroidism Diseases 0.000 claims 1
- 230000002989 hypothyroidism Effects 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000002708 enhancing effect Effects 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 241000700159 Rattus Species 0.000 abstract description 4
- 230000007423 decrease Effects 0.000 abstract description 3
- 230000028327 secretion Effects 0.000 abstract description 3
- 230000002381 testicular Effects 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 23
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 230000001965 increasing effect Effects 0.000 description 12
- 244000063299 Bacillus subtilis Species 0.000 description 10
- 235000014469 Bacillus subtilis Nutrition 0.000 description 10
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000009245 menopause Effects 0.000 description 7
- 241001474374 Blennius Species 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 229940093499 ethyl acetate Drugs 0.000 description 6
- 235000019439 ethyl acetate Nutrition 0.000 description 6
- 229940011871 estrogen Drugs 0.000 description 5
- 239000000262 estrogen Substances 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000000580 secretagogue effect Effects 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241001289529 Fallopia multiflora Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 238000008157 ELISA kit Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 235000013584 Tabebuia pallida Nutrition 0.000 description 3
- 235000008109 Thuja occidentalis Nutrition 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241001164374 Calyx Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241001627205 Leuconostoc sp. Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 244000236151 Tabebuia pallida Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000037180 bone health Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000003930 cognitive ability Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007413 intestinal health Effects 0.000 description 2
- 230000037231 joint health Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 230000037209 prostate health Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- -1 steroid compound Chemical class 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- GAKUNXBDVGLOFS-DUZKARGPSA-N (1-acetyloxy-3-hexadecanoyloxypropan-2-yl) (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COC(C)=O)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC GAKUNXBDVGLOFS-DUZKARGPSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 244000056139 Brassica cretica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 244000060701 Kaempferia pandurata Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010024238 Leptospirosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 235000010801 Platycodon sp Nutrition 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000123889 Rubus chingii Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 240000005499 Sasa Species 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000016390 Uvaria chamae Nutrition 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 210000005226 corpus cavernosum Anatomy 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000009986 erectile function Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000002570 interstitial cell Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229930193739 panduratin Natural products 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A23L1/3002—
-
- A23L1/0014—
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 테스토스테론 분비 증강 효과를 갖는 백수오 추출물을 포함하는 건강식품 조성물에 관한 것이다. 보다 구체적으로는 천연원료인 백수오(白首烏, Cynanchum
wilfordii Hemsley)로 추출물을 이용하여 독성 및 부작용 없이 안전하게 사용될 수 있는 갱년기 남성의 테스토스테론 감소로 인한 질환 예방 또는 개선을 위한 건강식품 조성물에 관한 것이다.
The present invention relates to a health food composition comprising a white water extract having a testosterone secretagogue enhancing effect. More particularly, the present invention relates to a health food composition for preventing or ameliorating a disease caused by reduction of testosterone in a menopausal male who can be safely used without toxicity and side effects by using an extract as a natural raw material ( Cynanchum wilfordii Hemsley) .
하수오는 땅속으로 뻗는 뿌리는 둥근 덩이뿌리를 형성한다. 가늘게 뻗는 줄기는 전체에 털이 없고 잎이 어긋나게 달린다. 잎은 잎자루가 있고 예두, 심장저로 가장자리가 밋밋하다. 8~9월에 가지 끝에서 흰색의 꽃이 원추화서로 달리는데 꽃잎은 없으며 꽃받침은 5개로 갈라진다. 8개의 수술과 3개의 암술대가 있다. 수과인 열매는 날개가 있고 꽃받침에 싸여있다. 중국 원산으로 우리나라에 귀화한 덩굴성 다년생 초본이다. 흔히 우리나라 각지의 산야에 야생하고 내한성, 내충성, 내건성 등이 강해 전국 어디서나 재배가 가능하다.Sasao has roots that reach into the ground, forming round root roots. The narrow stem has no hairs in the whole, and the leaves are staggered. The leaves have petiole, the edge is flat, the edge is flat. From August to September, the white flower at the end of the branch runs on each other. There are no petals, and the calyx is divided into 5 pieces. There are eight stamens and three styles. The achene fruit has wings and is wrapped in calyx. It is a perennial herbaceous perennial native to China, native to China. It is possible to cultivate everywhere in the country because it is wild, cold tolerant, insecticidal, resistant to weather, etc.
하수오(何首烏)는 적색과 백색 두 종류가 있는데 백하수오(白何首烏)는 백색의 하수오를 일컫는 것으로 박주가리과(Asclepiadaceae) 큰조롱(Cynanchum wilfordii Hemsley) 이며, 생약명은 백수오이다. 조롱, 새박풀, 해숭애, 새조롱, 곱뿌리 등의 다른 이름으로 불리기도 하며 자양강장, 보혈(補血), 익정(益精), 소종(消腫)의 효능이 있어, 병후쇠약, 빈혈, 조기백발(早期白髮), 신경쇠약, 만성풍비(慢性風痺) 등에 사용한다.There are two kinds of red and white seaweeds. White cedar is white cedar ( Cynanchum wilfordii Hemsley), which is white cedar (Asclepiadaceae). They are also called other names such as mockery, dwarf grass, sunshine, new mockery, multipurpose roots and have the efficacy of nourishment, blood, blood, It is used for early white hair (early white hair), nervous breakdown, and chronic air bloom.
적하수오(赤何首烏; Polygonum multiflorum)는 보간(補肝), 익신(益腎), 양혈(養血), 거풍(祛風), 영심안신(寧心安神), 익정(益精), 견골(堅骨), 화기혈(和氣血), 화허담(化虛痰), 오수발(烏鬚髮), 열안색(悅顔色), 구복(久服): 익정수(益精髓), 장근골(長筋骨), 연년불로(延年不老)하는 효능이 있는 약재임Polygonum multiflorum has been used for the treatment of liver diseases such as interpolation, xyphosis, hemorrhage, giant wind, Ningxian God, (髓 精 髓), 정수 (((髓 鬚 痰), 정수 鬚 鬚, 悅 鬚), Long striae), a yearly fever
하수오(何首烏, Polygonummultiflorum Thunberg)는 마디풀과에 속하는 다년생 초본인 3-4년 된 하수오의 괴근을 채취하여 건조한 것이다. 여기서, 하수오는 적하수오(赤何首烏)를 의미하는 것으로서, 우리나라와 북한에서는 전통적으로 하수오류 약재를 적하수오 및 백하수오로 구분하여 규정하고 있다. 대한약전외한약규격집에서는 적하수오를 하수오로, 백하수오를 백수오(白首烏, Cynanchum wilfordii Hemsley)로 구분하여 규정하고 있고 식품의약품안전처에서도 백수오와 하수오를 구분하고 있다(표 1 참조). Polygonummultiflorum Thunberg is a dried perennial herbaceous perennial herbaceous plant belonging to the family Porphyra spp., 3-4 years old. In Korea and North Korea, it is traditionally defined that the phytochemicals of sewage are classified into the red sea water and the white sea water. In the Korean Pharmacopoeia, the Korean herbal medicine standard set the enemy seaweed to the seaweed, the white seaweed to the white seaweed (white warriors, Cynanchum wilfordii Hemsley), and the Korea Food and Drug Administration (KFDA) distinguishes Hwaseo and Hwaseo (see Table 1).
한편, 갱년기란 일반적으로 여성의 성숙기가 종말기(終末期)에 이르면 난소의 기능은 점차 위축하여 배란작용이 불규칙해지고, 황체 호르몬의 형성이 완전하지 못하여 생식기관이 쇠퇴하기에 이르는데, 이 시기를 갱년기라고 한다. 대개 여성들은 45세를 전후하여 갱년기에 이른다. 이 시기에는 심계항진(心悸亢進), 흥분, 불안, 초조 등의 증상이 나타나며, 더욱 진행하면 완전한 월경 폐지가 오는데, 그 기간은 1~3년에 걸친다. 요법으로는 여성 호르몬의 보충이 필요하다.On the other hand, menopausal period generally means that when the mature stage of the female reaches the terminal period, the function of the ovary gradually decreases and the ovulation function becomes irregular, the formation of the progesterone is not complete and the reproductive organs decline, Is called a menopause. Most women reach the menopause around the age of 45. During this period, symptoms such as heart palpitations, excitement, anxiety, and irritability develop, and further progression results in complete abolition of the menstrual cycle, which lasts for one to three years. It is necessary to supplement female hormone therapy.
여성호르몬은 난소에서 분비되는 난포호르몬인 에스트로겐(estrogen)과 황체호르몬인 프로게스테론(progesteron)을 의미하나, 일반적으로 여성 호르몬은 에스트로겐을 지칭하는 용어로 많이 사용된다. 에스트로겐은 생리, 임신, 그리고 폐경에 이르는 여성의 일생을 조절하는 여성 호르몬이다. 인체의 에스트로겐 농도는 뇌에서 간장, 뼈에 이르기까지 광범위한 조직과 기관에 영향을 미치며 특히 자궁, 비뇨기, 유방, 피부, 그리고 혈관들이 유연성과 정상상태를 유지하는데 에스트로겐이 필요하다.Female hormone is the estrogen and progesterone, which are follicular hormones secreted from the ovaries. Generally, female hormones are often used to refer to estrogen. Estrogen is a female hormone that regulates the lifespan of women through menstruation, pregnancy, and menopause. Estrogen levels in the body affect a wide range of tissues and organs, from the brain to the liver and bone, and estrogen is especially needed to maintain flexibility and steady state of the uterus, urinary, breast, skin, and blood vessels.
이와 같이 종래의 갱년기는 여성의 갱년기를 지칭하는 의미로 사용되어왔으나, 최근 식생활 변화등으로 인한 남성의 갱년기 문제가 대두됨에 따라 건강기능성 식품분류에서는 여성 갱년기와 남성갱년기를 구분하기에 이르렀다. 표 1에는 2013년도 건강기능성 식품분류의 기능성 내용별 원료 인정 현황을 나타낸다.Thus, conventional menopause has been used to refer to women's menopause, but recently men's menopause problems due to dietary changes have led to the classification of health functional foods to distinguish between female and menopausal menstrual periods. Table 1 shows the status of raw material approval by functional content of the 2013 health functional food classification.
개선Irritable skin condition
Improving
남성 갱년기와 관련 있는 남성호르몬으로는 테스토스테론을 들 수 있는데, 테스토스테론은 정소의 간질세포로서 하수체의 성선자극호르몬의 지배하에 콜레스테롤에서 생성되는 스테로이드 화합물이다. 남성의 2차 성징의 발현, 정자형성의 촉진, 정소상체, 전립선, 정낭 등의 발육작용을 가지며, 단백질의 동화작용도 가지기 때문에 체내에 질소를 저류시키는 효과를 나타낸다.Testosterone is an interstitial cell of testis, a steroid compound that is produced by cholesterol under the control of the gonadal hormone in the lower body. It has an effect of accumulating nitrogen in the body because it has the expression of secondary sex of male, promotion of spermatogenesis, development of testis, prostate, seminal vesicle and also assimilating protein.
따라서 본 발명에서는 우리나라의 전통적인 식물자원을 활용할 목적으로 천연원료인 백수오(白首烏, Cynanchum wilfordii Hemsley)로 추출물을 이용하여 독성 및 부작용 없이 안전하게 사용될 수 있는 갱년기 남성의 테스토스테론 감소로 인한 질환 예방 또는 개선을 위한 테스토스테론 분비 증강 효과를 갖는 건강 기능성식품 조성물을 제공한다.
Accordingly, the present invention provides a method for preventing or reducing diseases caused by reduction of testosterone in a menopausal male who can be safely used without toxicity and side effects by using an extract of Cynanchum wilfordii Hemsley, a natural raw material, A health functional food composition having a testosterone secretagogue enhancing effect for improvement.
우리나라 천연자원인 백수오 추출물을 이용하여 독성 및 부작용없이 안전하게 사용될 수 있는 남성호르몬 테스토스테론 분비 증강 효과를 갖는 기능성 식품 조성물을 제공하고자 한다.
The present invention provides a functional food composition having a male hormone testosterone secretagogue enhancing effect which can be safely used without toxicity and side effects by using Baekgoo extract of natural Korean resource.
상기 목적을 달성하기 위하여, 본 발명은 백수오 추출물을 유효성분으로 포함하는 테스토스테론 분비 증강 기능을 갖는 기능성 식품 조성물을 제공한다.In order to accomplish the above object, the present invention provides a functional food composition having a testosterone secretion enhancing function comprising an extract of Bacillus subtilis as an active ingredient.
테스토스테론 분비 증강 기능을 갖는 기능성 식품 조성물의 추출방법은 백수오를 증류수로 수세한 다음 증류수와 혼합하여 열수추출 또는 탄소수 1 내지 5의 알코올 또는 이들의 혼합용매로 이루어진 군 중에서 선택된 1종 이상을 추출용매로 사용하여 추출할 수 있다.The method of extracting a functional food composition having a testosterone secretagogue enhancing function is characterized by comprising washing water with distilled water and then mixing it with distilled water to extract at least one selected from the group consisting of hot water extraction or an alcohol having 1 to 5 carbon atoms or a mixed solvent thereof as an extraction solvent .
상기 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 또는 이들의 혼합용매 중 어느 하나에서 가용한 추출물을 유효성분으로 포함하는 추출물은 0.01 내지 99.9 중량%의 양으로 포함하는 백수오 테스토스테론 분비 증강용 기능성 식품 조성물 및 기능성식품이 제공된다. The extract containing 0.01 to 99.9% by weight of the extract as an active ingredient, which is soluble in any one of water, methanol, ethanol, propanol, isopropanol, butanol or a mixed solvent thereof, Compositions and functional foods are provided.
상기 추출물을 조성물로하여 제조된 기능성 식품의 1일당 투여량은 체중 kg당 10 내지 2000 mg/kg의 양으로 포함하여 경구 투여하며, 본 발명의 테스토스테론 감소로 인한 질환으로는 테스토스테론 저하증, 발기부전, 정력 감소, 정자운동성 감소, 성욕감퇴, 체력 저하, 내장지방 증가로 이루어진 군에서 선택된 하나 이상의 남성 갱년기 질환 예방 또는 개선을 위한 기능성 식품 조성물 또는 약학적 조성물일 수 있다.The daily dose of the functional food prepared using the extract as a composition is orally administered in an amount of 10 to 2000 mg / kg per kg of body weight. The testosterone-lowering diseases of the present invention include testosterone hypoperfusion, erectile dysfunction, A functional food composition or a pharmaceutical composition for preventing or ameliorating at least one male menopausal disease selected from the group consisting of decreased urination, decreased sperm motility, decreased sexual desire, decreased physical strength, and increased visceral fat.
상기 기능성 식품 조성물은 정제 및 캡슐제, 연질 캡슐제, 과립제, 액제 또는 음료중에서 선택된 하나 이상의 형태로 제조될 수 있다.
The functional food composition may be prepared in one or more forms selected from tablets and capsules, soft capsules, granules, liquids or beverages.
본 발명의 테스토스테론 분비 증강 기능을 갖는 백수오 추출물은 레이디그(Leydig) TM3 고환세포 및 마우스 혈중의 테스토스테론 (Testosterone) 함량을 증가시킴으로써 테스토스테론 감소로 인한 질환의 예방 및 개선에 유용한 기능성 식품 조성물로 유용하게 이용될 수 있다.
The white water extract having the testosterone secretion enhancing function of the present invention is useful as a functional food composition useful for prevention and improvement of diseases due to reduction of testosterone by increasing testosterone content in Leydig TM3 testicular cells and mouse blood Can be used.
도 1은 백수오 추출물에 대한 Leyding TM3 세포에서 세포 독성을 확인한 결과를 나타낸다.
도 2는 백수오 추출물에 대한 Leyding TM3 세포에서 테스토스테론 증가 효과를 나타낸다.
도 3은 백수오와 산수유 추출물에 대한 Leyding TM3 세포에서 테스토스테론 증가 효과를 비교한 결과를 나타낸다.
도 4는 백수오 추출물에 대한 쥐에서의 테스토스테론 증가 효과를 나타낸다.FIG. 1 shows the results of cytotoxicity of Leyding TM3 cells against Bacillus subtilis extract.
FIG. 2 shows the effect of increasing testosterone in Leyding TM3 cells on Bacillus subtilis extract.
FIG. 3 shows the results of comparing the effect of testosterone increase in Leyding TM3 cells on Bacillus subtilis and Saponin extract.
Fig. 4 shows the effect of increasing testosterone in rats against Bacillus subtilis extract.
이하, 본 발명의 이해를 돕기 위하여 구체적인 실시예 및 비교예를 통하여 본 발명의 구성 및 효과를 보다 상세히 설명하기로 한다.
Hereinafter, the structure and effects of the present invention will be described in more detail with reference to specific examples and comparative examples in order to facilitate understanding of the present invention.
1. One. 백수오Baewooo Oh 추출물 제조 Extract preparation
건조된 백수오 50g을 증류수로 수세한 다음 증류수, 에탄올로 각각 500 mL를 가하여, 환류 추출기 100℃, 60℃ 에서 3시간 동안 가열, 추출하였다. 여과지(와트만 41번)를 이용하여 여과 한 후, 여액을 감압 농축하여 동결건조기를 이용하여 -50℃에서 48시간 동안 동결 건조시켰다. 이상의 방법으로 상기 추출물은 추출용매에 따라, 백수오 열수 추출물 28.74g (57.5%), 백수오 에탄올 추출물 12.31g (24.6%)을 각각 수득하여 하기 실험예의 시료로 사용하였다.
50 g of dried white water was washed with distilled water, and 500 mL was added with distilled water and ethanol, respectively, and the mixture was heated at 100 ° C. and 60 ° C. for 3 hours for extraction. After filtration using a filter paper (Watts 41), the filtrate was concentrated under reduced pressure and freeze-dried at -50 ° C for 48 hours using a freeze dryer. According to the above-mentioned method, 28.74 g (57.5%) of Baekgoo hot water extract and 12.31 g (24.6%) of Baechuoethanol extract were obtained according to the extraction solvent and used as a sample of the following experimental example.
1.1. 1.1. 백수오의White 극성용매, Polar solvent, 비극성용매Nonpolar solvent 가용 Available 분획물의Fraction 제조 Produce
증류수 1L에 완전히 용해시킨 후 분획 여두에 넣고 Hexane 1L를 첨가하여 water층과 hexane층을 분리하였고 이와 같은 공정을 3번 반복하였다. 동일한 과정을 통해 클로로포름(chloroform), 에틸아세테이트(ethylacetate), 부탄올(butanol)을 순차적으로 가하여 각 분획물을 얻었고, 얻어진 각각의 분획물을 감압여과 장치로 여과하여 농축한 후 동결 건조하여 용매를 완전히 제거한 뒤 본 실험에 사용하였다.After completely dissolving in 1 L of distilled water, 1 liter of hexane was added to the separating funnel to separate the water layer and the hexane layer. This process was repeated three times. Chloroform, ethylacetate and butanol were sequentially added through the same procedure to obtain fractions. Each of the fractions thus obtained was filtered through a vacuum filtration apparatus and concentrated. After freeze-drying, the solvent was completely removed It was used in this experiment.
1.1.1. 헥산 가용성 분획 분리1.1.1. Hexane-soluble fraction separation
상기 백수오 열수추출물 28.74g을 lL의 증류수에 완전히 용해시킨 후에 분획여두에 넣고 헥산 1L를 첨가하여 헥산 불용성층(수층)과 헥산가용성층을 분리하였다. 다시 헥산 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 헥산 불용성 분획물 및 가용성 분획물을 수집하였다.
After completely dissolving 28.74 g of the hydrothermal extract of Bacillus subtilis in 1 L of distilled water, the mixture was put into a separatory funnel and 1 L of hexane was added to separate the hexane insoluble layer (water layer) and the hexane soluble layer. The hexane insoluble fraction (water layer) was again subjected to the same process three times to collect hexane insoluble fraction and soluble fraction.
1.1.2. 클로로포름 가용성 분획분리1.1.2. Chloroform-soluble fractionation
헥산불용성 분획(수층)에 클로로포름 1L를 가하여 섞은 후에 클로로포름가용성 분획 및 불용성 분획을 분리하였고, 클로로포름 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 클로로포름 불용성 분획물 및 가용성 분획물을 수집하였다.
The chloroform-insoluble fraction (water layer) was mixed with 1 L of chloroform, and then the chloroform-soluble fraction and the insoluble fraction were separated. The chloroform-insoluble fraction (water layer) was subjected to the same process three times to collect chloroform-insoluble fractions and soluble fractions.
1.1.3. 에틸아세테이트 가용성 분획분리1.1.3. Ethyl acetate soluble fraction separation
클로로포름 불용성 분획(수층)에 에틸아세테이트 1L를 가하여 섞은 후에 에틸아세테이트 가용성 분획 및 불용성 분획을 분리하였고, 에틸아세테이트 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 에틸아세테이트 불용성 분획물 및 가용성 분획물을 수집하였다.
To the chloroform insoluble fraction (water layer), 1 L of ethyl acetate was added and mixed. Then, the ethyl acetate soluble fraction and the insoluble fraction were separated. The ethyl acetate insoluble layer (water layer) was subjected to the same process three times to obtain an ethyl acetate insoluble fraction and a soluble fraction Respectively.
1.1.4. 부탄올 가용성 분획분리1.1.4. Butanol soluble fraction fractionation
상기 에틸아세테이트 불용성 분획(수층)에 부탄올 1L를 가하여 섞은 후에 부탄올 가용성 분획 및 불용성 분획을 분리하였고, 부탄올 불용성층을 대상으로 동일한 공정을 3번 반복하여 부탄올 불용성 분획물 및 가용성 분획물을 수집하였다.The ethanolic insoluble fraction (water layer) was mixed with 1 L of butanol, and the butanol-soluble fraction and the insoluble fraction were separated. The butanol-insoluble fraction was repeated three times to collect the butanol insoluble fraction and the soluble fraction.
상기 헥산 가용성 분획, 클로로포름 가용성 분획, 에틸아세테이트 가용성 분획 및 부탄올 가용성 분획을 감압 농축한 후에 동결 건조하여 분획물을 얻어 시료로 사용하였다.
The hexane-soluble fraction, the chloroform-soluble fraction, the ethyl acetate-soluble fraction and the butanol-soluble fraction were concentrated under reduced pressure and then lyophilized to obtain fractions.
2. 2. 백수오Baewooo Oh 추출물에 의한 By extract LeydigLeydig TM3TM3 cellcell 에서 세포 독성 영향 실험Cytotoxic effect experiments
Leyding TM3 cell을 37℃, 5% CO2 조건에서 10% FBS가 첨가된 DMEM 배지로 배양하였다. Leyding TM3 세포를 1×105 cells/mL가 되도록 희석하여 24 well plate에 분주한 다음 37℃, 5% CO2 incubator에서 24시간 배양하여 백수오 추출물을 0, 10, 50, 100 및 200 μg/mL의 농도로 첨가하고 48시간 동안 반응시킨 후 MTT 용액 300 uL를 첨가하여 2시간 배양한 후 상층액을 제거하여 DMSO를 well 당 100 uL 씩 첨가한 후 ELISA autoreader 570 nm에서 흡광도를 측정하였다.Leyding TM3 cells were cultured in DMEM medium supplemented with 10% FBS at 37 ° C and 5% CO 2 . One Leyding TM3 cells were diluted to 1 × 10 5 cells / mL and then dispensed in a 24 well plate 37 ℃, 5% CO 2 After incubation for 24 hours in an incubator, the extracts were added at concentrations of 0, 10, 50, 100 and 200 μg / mL for 48 hours. Then, 300 μL of MTT solution was added for 2 hours and then the supernatant was removed DMSO was added at 100 uL per well and absorbance was measured at 570 nm in an ELISA autoreader.
도 1은 백수오 추출물에 대한 Leyding TM3 세포에서 세포 독성을 확인한 결과를 나타낸다. 측정결과에 의하면 백수오 추출물은 실험에 사용된 농도 (10, 50, 100, 200 ug/mL)에서 Leyding TM3 세포에 독성을 나타내지 않음을 확인하였다.
FIG. 1 shows the results of cytotoxicity of Leyding TM3 cells against Bacillus subtilis extract. According to the measurement results, it was confirmed that Bacillus subtilis extract did not show toxicity to Leyding TM3 cells at the concentrations (10, 50, 100, 200 ug / mL) used in the experiment.
3. 3. 백수오Baewooo Oh 추출물에 의한 By extract LeydigLeydig TM3TM3 cellcell 에서 테스토스테론 증가 효과실험Testosterone increase effect test
Leyding TM3 cell을 37℃, 5% CO2 조건에서 10% FBS가 첨가된 DMEM 배지로 배양하였다. Leyding TM3 세포를 1×105 cells/mL가 되도록 희석하여 24 well plate에 분주한 다음 37℃, 5% CO2 incubator에서 24시간 배양하여 백수오 추출물을 0, 10, 50, 100 및 200 μg/mL의 농도로 첨가하고 48시간 동안 반응시킨 후 1200 rpm에서 5분간 원심 분리하여 상등액만 취한 후 Testosterone ELISA kit (ADI-901-093, 065, 174; Enzo Life Sciences, U.S.A.)을 이용하여 테스토스테론 함량을 측정하였다. Leyding TM3 cells were cultured in DMEM medium supplemented with 10% FBS at 37 ° C and 5% CO 2 . One Leyding TM3 cells were diluted to 1 × 10 5 cells / mL and then dispensed in a 24 well plate 37 ℃, 5% CO 2 The testosterone ELISA kit (ADI) was prepared by centrifugation at 1200 rpm for 5 min. The supernatant was collected by centrifugation at 1200 rpm for 24 hrs. The extracts were added at 0, 10, 50, 100 and 200 μg / Testosterone content was measured using Enzo Life Sciences, USA, at -901-093, 065, 174.
도 2는 백수오 추출물에 대한 Leyding TM3 세포에서 테스토스테론 증가 효과를 나타낸다. 도 2에 나타낸 바와 같이 백수오 추출물을 레이디그 (Leydig) TM3 세포에 10, 50, 100, 200 ug/ml 농도로 처리 시 각각 88.2 pg/ml, 125.3 pg/ml, 178.4 pg/ml, 236.2 pg/ml 테스토스테론 함량이 증가하였다.
FIG. 2 shows the effect of increasing testosterone in Leyding TM3 cells on Bacillus subtilis extract. As shown in FIG. 2, the extracts of Bacillus thuringiensis were treated at a concentration of 10, 50, 100 and 200 ug / ml in Leydig TM3 cells at 88.2 pg / ml, 125.3 pg / ml, 178.4 pg / ml, 236.2 pg / ml testosterone content increased.
4. 4. 백수오와Baisho Owa 산수유 추출물의 Of corn oil extract LeydigLeydig TM3TM3 cellcell 에서 테스토스테론 증가 비교 Increased testosterone in comparison
Leyding TM3 cell을 37℃, 5% CO2 조건에서 10% FBS가 첨가된 DMEM 배지로 배양하였다. Leyding TM3 세포를 1×105 cells/mL가 되도록 희석하여 24 well plate에 분주한 다음 37℃, 5% CO2 incubator에서 24시간 배양하여 백수오 추출물 및 산수유 추출물을 100 및 200 μg/mL의 농도로 첨가하고 48시간 동안 반응시킨 후 1200 rpm에서 5분간 원심 분리하여 상등액만 취한 후 Testosterone ELISA kit (ADI-901-093, 065, 174; Enzo Life Sciences, U.S.A.)을 이용하여 테스토스테론 함량을 측정하였다.Leyding TM3 cells were cultured in DMEM medium supplemented with 10% FBS at 37 ° C and 5% CO 2 . One Leyding TM3 cells were diluted to 1 × 10 5 cells / mL and then dispensed in a 24 well plate 37 ℃, 5% CO 2 The testosterone ELISA kit (ADI-901-C) was prepared by centrifugation at 1200 rpm for 5 min. The supernatant was then centrifuged at 1200 rpm for 24 h. 093, 065, 174; Enzo Life Sciences, USA).
도 3은 백수오와 산수유 추출물에 대한 Leyding TM3 세포에서 테스토스테론 증가를 비교한 실험결과를 나타낸다. 도 3에 나타낸 바와 같이 백수오 추출물과 산수유 추출물을 레이디그 (Leydig) TM3 세포에 각각 100, 200 ug/ml 농도로 처리하여 테스토스테론 함량을 비교 한 결과, 백수오 추출물이 산수유 추출물 보다 테스토스테론 함량을 4배정도 증가시킨 것으로 나타났다.
FIG. 3 shows experimental results comparing the increase of testosterone in Leyding TM3 cells with the extracts of Leuconostoc sp. As shown in FIG. 3, the testosterone content of Leydig TM3 cells was 100 and 200 ug / ml, respectively. The testosterone content of Leydig TM3 was higher than that of the L. acidophilus extract But also increased the number of times.
5. 5. 백수오Baewooo Oh 추출물 섭취로 인한 Due to ingestion of extracts 쥐에서In rats 테스토스테론 증가 효과 실험 Testosterone increase effect experiment
생후 10 주령 수컷 mouse를 아무것도 섭취하지 않은 대조군, 백수오 추출물을 섭취한 실험군으로 나누어 각각 10 마리씩을 본 실험에 이용하였다. 사육기간 중에는 쥐 고형사료와 수돗물을 자유롭게 섭취하도록 하였고, 매일 오전 같은 시각에 증류수에 녹인 백수오 물추출물 및 백수오 에탄올 추출물을 200 mg/kg의 농도로, 대조군은 동일량의 생리식염수를 4주 동안 경구투여 하였다.Male 10-week-old male mice were divided into two groups, one was a control group and the other was a control group. During the breeding period, mice were given free access to solid feeds and tap water. At the same time of day, the water extracts of Bacillus officinalis and Bacillus oxyethans dissolved in distilled water were administered at a concentration of 200 mg / kg, and the control group was given the same amount of physiological saline for 4 weeks Lt; / RTI >
마지막 경구 투여 후 마우스 꼬리로부터 혈액을 채취 한 후, 10000 rpm에서 10분간 원심 분리하여 혈청을 분리하였다. 분리된 혈청을 Testosterone ELISA kit (ADI-901-093, 065, 174; Enzo Life Sciences, U.S.A.)을 이용하여 혈중 테스토스테론 함량을 측정하였다.After the last oral administration, blood was collected from the tail of the mouse, and the serum was separated by centrifugation at 10000 rpm for 10 minutes. Testosterone ELISA kit (ADI-901-093, 065, 174; Enzo Life Sciences, U.S.A.) was used to measure the serum testosterone content.
도 4는 백수오 추출물에 대한 쥐에서의 테스토스테론 증가 효과를 나타낸다. 마우스 혈액으로부터 테스토스테론 함량을 측정결과는 도 4에 나타낸 바와 같이 PBS를 섭취한 대조군의 테스토스테론 함량은 109.4 pg/ml 이었으며, 백수오 물 추출물 (200 mg/kg), 백수오 에탄올 추출물 (200 mg/kg) 섭취한 군에서는 테스토스테론 함량이 각각 1100 pg/ml, 1200 pg/ml로 나타났다.Fig. 4 shows the effect of increasing testosterone in rats against Bacillus subtilis extract. As shown in FIG. 4, the testosterone content of the control group fed with PBS was 109.4 pg / ml, and the amount of testosterone was 200 mg / kg, 200 mg / kg ), The testosterone contents were 1100 pg / ml and 1200 pg / ml, respectively.
이상의 결과로부터 백수오 물추출물 및 에탄올 추출물은 마우스 혈중 테스토스테론 함량을 대조군에 비하여 각각 10%, 10.9% 증가시킨 것으로 나타났다.
From the above results, it was shown that the white wool water extract and the ethanol extract increased the testosterone content in the mouse blood by 10% and 10.9%, respectively.
6. 6. 백수오Baewooo Oh 추출물을 Extract 조성물로하는As a composition 건강 기능성 식품제조 Health Functional Food Manufacturing
백수오 추출물을 유효성분으로 포함하는 테스토스테론 분비 증강 효과를 갖는 건강기능성 식품은 상기 조성물이 0.01 내지 99.9중량%로 포함되도록 정제 및 캡슐제, 연질 캡슐제, 과립제, 액제 형태로 제조될 수 있고 음료로 변형 제조가능하다. 상기 건강 기능성 식품에는 백수오 추출물이 1일, 체중kg당 10 내지 2000 mg/kg 함량으로 투여되는 양으로 제조할 수 있다.The health functional food having a testosterone secretagogue enhancing effect containing Baekgoo extract as an active ingredient may be prepared in the form of tablets and capsules, soft capsules, granules, and liquid preparations such that the composition is contained in an amount of 0.01 to 99.9% by weight, Modifications are possible. The health functional food may be produced in an amount such that the white water extract is administered in an amount of 10 to 2000 mg / kg per kg body weight per day.
본 발명의 건강 기능성 음료 조성물은 상기 성분을 함유하는 외의 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.The health functional beverage composition of the present invention is not particularly limited to the components other than those containing the above components, and may contain various flavors or natural carbohydrates as additional components such as ordinary beverages.
상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당; 디사카라이드, 예를 들어 말토스, 슈크로스 등 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상술한 것 이외에 향미제로써 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.Examples of the above-mentioned natural carbohydrates are monosaccharides such as glucose, fructose; Disaccharides such as maltose, sucrose and the like and polysaccharides such as dextrins, cyclodextrins and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. In addition to the above, natural flavoring agents (tau martin, stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavorings.
상기 외에 본 발명의 성분은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 추가로 함유할 수 있다. 그 밖에 본 발명의 성분은 천연 과일 주스 및 과일 주스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition to the above-mentioned components, the components of the present invention can be suitably used as flavorings such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, coloring agents and intermediates such as cheese and chocolate, pectic acid and its salts, A colloidal thickening agent, a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, a carbonating agent used in a carbonated drink, and the like. In addition, the components of the present invention may contain flesh for the production of natural fruit juices and fruit juice drinks and vegetable drinks.
이상의 건강기능성 식품은 테스토스테론 저하증, 발기부전, 정자운동성 감소, 성욕감퇴, 정력감소, 체력저하, 내장지방 증가 등의 테스토스테론 감소로 인한 남성 갱년기 질환 예방 또는 개선에 효과가 있다.
These health functional foods are effective in preventing or ameliorating male menopausal symptoms due to decreased testosterone such as hypo-testosterone, erectile dysfunction, decreased sperm motility, loss of sexual desire, decreased tack, decreased physical strength, and increased visceral fat.
본 발명의 백수오 추출물을 이용한 백수오 추출물을 유효성분으로 함유하는 테스토스테론 증강용 식품 조성물에 관한 것으로서, 백수오 추출물은 레이디그 (Leydig) 고환세포 및 마우스 혈중의 테스토스테론 (Testosterone) 함량을 증가시켜, 테스토스테론 감소로 인한 질환의 예방 및 개선에 탁월한 효과를 가질 뿐만 아니라 천연물질 유래의 것으로 부작용이나 독성의 문제가 발생될 가능성이 적으므로, 본 발명은 남성갱년기 질환의 개선, 예방 및 치료에 효과가 있어 안전한 의약 조성물 또는 기능성 식품 조성물서 산업적 이용 가능성이 있다.The present invention relates to a food composition for enhancing testosterone which contains as an active ingredient an extract of Leuconostoc sp. Using an extract of Leptospirosis extract of the present invention. The extract of Leucocyte extract increases the testosterone content in Leydig testis cells and mouse blood, The present invention not only has an excellent effect for prevention and improvement of diseases due to reduction in testosterone but also has a low possibility of occurrence of side effects or toxicity due to natural substances and thus the present invention is effective for the improvement, There are industrial applicability in safe pharmaceutical compositions or functional food compositions.
Claims (6)
White Shuo (White Sheep, Cynanchum wilfordii Hemsley) extract as an active ingredient. The present invention relates to a health functional food composition for preventing or ameliorating menopausal diseases
The health functional food composition for preventing or ameliorating menopausal symptoms according to claim 1, wherein the white water extract is an extract obtained from water, a lower alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof.
A health functional food composition for preventing or ameliorating male menopausal disease characterized by containing the health functional food composition of claim 1 or 2 as an active ingredient
4. The health functional food composition according to claim 3, wherein the health functional food is prepared by incorporating white water extract in an amount of 10 to 2000 mg / kg of body weight per day
The health functional food composition according to claim 4, wherein the health functional food is prepared in the form of tablets, capsules, soft capsules, granules, liquid form
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150132380A KR20160011174A (en) | 2015-09-18 | 2015-09-18 | Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150132380A KR20160011174A (en) | 2015-09-18 | 2015-09-18 | Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140091636 Division | 2014-07-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20160011174A true KR20160011174A (en) | 2016-01-29 |
Family
ID=55310214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150132380A KR20160011174A (en) | 2015-09-18 | 2015-09-18 | Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20160011174A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017010735A1 (en) * | 2015-07-10 | 2017-01-19 | 주식회사 브레인온 | Composition, containing extracts of dipsacus asperoides and cynanchum wilfordii as active ingredients, for promoting motor ability and muscles |
KR20180054191A (en) | 2016-11-15 | 2018-05-24 | 대한민국(농촌진흥청장) | A composition for improving immune comprising cynanchi wilfordii radix extract or cynanchi wilfordii radix fraction |
KR20180124426A (en) * | 2017-05-11 | 2018-11-21 | 제주대학교 산학협력단 | Composition for Increas of Muscle Growth or Improvement of Exercise Performance Using Alcalase Hydrolysates of Hippocampus abdominalis |
KR20190048431A (en) | 2017-10-31 | 2019-05-09 | 한국식품연구원 | A composition for improving, preventing and treating of colitis diseases comprising cynanchi wilfordii radix fraction |
KR20220083293A (en) | 2020-12-11 | 2022-06-20 | 농업회사법인 주식회사 장수식품 | A composition comprising fermented onion for improving or preventing colitis diseases |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101113593B1 (en) | 2011-02-14 | 2012-03-06 | 재단법인 진안홍삼연구소 | A pharmaceutical comprising the extract of red panax ginseng, gastrodia rhizoma and polygoni multiflori radix for treating or preventing erectile dysfunction |
KR101295125B1 (en) | 2011-04-21 | 2013-08-09 | 우석대학교 산학협력단 | A pharmaceutical with anti-oxidative activity, and a healthful food with the pharmaceutical |
-
2015
- 2015-09-18 KR KR1020150132380A patent/KR20160011174A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101113593B1 (en) | 2011-02-14 | 2012-03-06 | 재단법인 진안홍삼연구소 | A pharmaceutical comprising the extract of red panax ginseng, gastrodia rhizoma and polygoni multiflori radix for treating or preventing erectile dysfunction |
KR101295125B1 (en) | 2011-04-21 | 2013-08-09 | 우석대학교 산학협력단 | A pharmaceutical with anti-oxidative activity, and a healthful food with the pharmaceutical |
Non-Patent Citations (1)
Title |
---|
그러나 상기 조성물에 사용되는 하수오(何首烏, Polygonum multiflorum Thunberg)는 적하수오를 의미하는 것으로 본원발명의 재료로 사용되는 백하수오와는 차이를 갖는다. |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017010735A1 (en) * | 2015-07-10 | 2017-01-19 | 주식회사 브레인온 | Composition, containing extracts of dipsacus asperoides and cynanchum wilfordii as active ingredients, for promoting motor ability and muscles |
KR20180054191A (en) | 2016-11-15 | 2018-05-24 | 대한민국(농촌진흥청장) | A composition for improving immune comprising cynanchi wilfordii radix extract or cynanchi wilfordii radix fraction |
KR20180124426A (en) * | 2017-05-11 | 2018-11-21 | 제주대학교 산학협력단 | Composition for Increas of Muscle Growth or Improvement of Exercise Performance Using Alcalase Hydrolysates of Hippocampus abdominalis |
KR20190048431A (en) | 2017-10-31 | 2019-05-09 | 한국식품연구원 | A composition for improving, preventing and treating of colitis diseases comprising cynanchi wilfordii radix fraction |
KR20220083293A (en) | 2020-12-11 | 2022-06-20 | 농업회사법인 주식회사 장수식품 | A composition comprising fermented onion for improving or preventing colitis diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baliga et al. | A review of the chemistry and pharmacology of the date fruits (Phoenix dactylifera L.) | |
KR20160011174A (en) | Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient | |
KR101339706B1 (en) | A compound for immune strengthen inclusion reducing the bitterness of red ginseng, the extract of immune, and the probiotics | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
CN110354204B (en) | Composition with eyesight improving effect and preparation and application methods thereof | |
KR20160144791A (en) | Composition for relieving menopausal symptom | |
KR20180137174A (en) | Health supplementing food for enhancing hair restoration, alleviating and improving hair loss | |
KR20130114960A (en) | Herbal composition for prevention and treatment of hepatic disease | |
Basharat et al. | Nutritional and functional profile of carob bean (Ceratonia siliqua): A comprehensive review | |
CN107751993A (en) | A kind of antifatigue cream taste and preparation method thereof | |
KR102022263B1 (en) | A composition comprising the fermented extract of Cinnamomum verum J. Presl, Ulmus davidiana var. japonica da and Acanthopanax sessiliflorum Seeman for preventing and treating benign prostatic hyperplasia | |
KR20130121324A (en) | Composition for preventing and treating hangover comprising extracts of leaves of perilla frutescens britton var | |
KR100549089B1 (en) | A Health Care Composition for treating or preventing intestinal disease and constipation | |
CN110051815A (en) | A kind of auxiliary hyperglycemic food ball and preparation method thereof | |
KR20190123921A (en) | A method for preparing functional pills comprising extracts of natural materials | |
KR20160011175A (en) | Food composition comprising cynanchum wilfordii potentiating testosterone excretion as an active ingredient | |
KR20220095717A (en) | Health functional food for diet and method for preparing the same | |
KR102167812B1 (en) | Fermented product of sorghum-adzuki bean mixture for intestinal health and improvement effect of bowel | |
KR101350046B1 (en) | Vinegar composition fermented with herbal extracts and preparation method thereof | |
KR100506824B1 (en) | Crude Drug Compositions for treating or preventing intestinal disease and constipation | |
KR101456127B1 (en) | A composition for increasing bone growth | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
CN102640893B (en) | Black malt and whole herb composite nutrient and preparation method thereof | |
KR101811227B1 (en) | Composition for Immune Enhancement, Fatigue Recovery, Physiologically Active, Detoxification Comprising Extracts of Lycium chinence miller, Rubus coreanus Miq. & Schisandra chinensis | |
CN106138591A (en) | Containing Fructus Lycii and the maca composition of Qi-tonifying drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |